Condition
Arrhythmic Storm
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 3 (1)
Trial Status
Recruiting1
Unknown1
Enrolling By Invitation1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05720936RecruitingPrimary
In-hospital Stellate Ganglion Block for Arrhythmic Storm
NCT05258422Phase 2Enrolling By Invitation
Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT)
NCT05078684Phase 3Unknown
GANGlion Stellate Block for Treatment of Electric storRm (GANGSTER Trial)
Showing all 3 trials